Source Count: 21 | Weighted Score: 38 | Source Confidence: [4/5] | Primary Tier: 2 | Last Updated: March 13, 2026
Keywords: Salvia divinorum, salvinorin A, kappa-opioid receptor, Mazatec, divination, sage, dissociative, hallucinogen, ska María Pastora, entheogen, diterpenoid, altered states
Category Tags: altered-states, ethnobotany, kappa-opioid, Mazatec, psychoactive-plants
Cross-References: Y_1_01 — Psychedelics · P_4_12 — Mesoamerican Shamanism · X_2_11 — Ethnobotanical Pharmacology

QUICK SUMMARY

Salvia divinorum ("diviner's sage") is a psychoactive plant of the mint family (Lamiaceae) native to the cloud forests of the Sierra Mazateca in Oaxaca, Mexico, where it has been used for centuries by Mazatec healers and curanderos in ceremonial divination and healing rituals — referred to as ska María Pastora ("leaves of Mary the Shepherdess"). The plant's active compound, salvinorin A, is pharmacologically unique among psychoactive substances — it is a potent and highly selective kappa-opioid receptor (KOR) agonist with no activity at the serotonin 5-HT2A receptor that mediates the effects of classical psychedelics (LSD, psilocybin, DMT). Salvinorin A is also the first known non-alkaloid opioid receptor ligand found in nature — it is a neoclerodane diterpenoid, chemically unrelated to any other known psychoactive compound. The subjective effects of smoked salvinorin A are extraordinarily intense but brief (typically 5–15 minutes): users report radical distortions of body perception (feeling pulled, stretched, or merged with objects), vivid visionary states, encounters with entity-like presences, complete disconnection from consensus reality, and a quality of experience frequently described as utterly unlike classical psychedelics — often characterized by a sense of the "uncanny," spatial disorientation, and sometimes terror. The traditional Mazatec method of ingestion (chewing fresh leaves, producing a slower and gentler experience) differs markedly from the modern practice of smoking concentrated extracts, which produces an almost instantaneous and overwhelming experience. Salvia divinorum is legal in many jurisdictions but has been banned or restricted in some US states and countries following media attention to recreational use.

1. VERIFIED CLAIMS (Tier 1 — Peer-Reviewed / Established)

1.1 Botany and Ethnobotany

• Salvia divinorum: a perennial herb of the mint family (Lamiaceae), growing to 1–1.5 meters in the humid cloud forests of the Sierra Mazateca (Oaxaca, Mexico) at elevations of 300–1,800 meters; the plant rarely sets seed and is primarily propagated by cuttings — raising questions about whether it may be a cultigen (a plant maintained by human cultivation rather than natural selection)
• Mazatec traditional use: Mazatec curanderos (healers) use Salvia divinorum as a divination and healing tool — leaves are typically chewed fresh (creating a quid held in the mouth against the buccal mucosa, allowing slow absorption) or prepared as an aqueous infusion; the experience is described as quieter, longer-lasting, and more controlled than the intense flash of smoked extracts
• The plant was first documented for Western science by R. Gordon Wasson and Albert Hofmann (who identified it as a Salvia species in the 1960s), though its psychoactive properties were not well characterized until much later; Leander Valdés III conducted early detailed ethnobotanical and pharmacological studies (1983–1994)

1.2 Pharmacology

• Salvinorin A: the primary psychoactive constituent — a neoclerodane diterpenoid (not an alkaloid); active at doses as low as 200–500 micrograms when smoked, making it one of the most potent naturally occurring psychoactive substances known
• Salvinorin A is a potent and highly selective kappa-opioid receptor (KOR) agonist — it has no significant activity at 5-HT2A serotonin receptors (the primary target of classical psychedelics), dopamine receptors, or mu-opioid receptors
• KOR activation produces dysphoria, perceptual distortions, and dissociative effects — distinct from the euphoria of mu-opioid agonists and the sensory/perceptual effects of serotonergic psychedelics

1.3 Effects and Duration

• Smoked salvinorin A (or concentrated leaf extracts marketed as "5x," "10x," etc.): onset within 30 seconds, peak effects lasting 5–10 minutes, residual effects fading within 30–60 minutes
• Common subjective effects: radical distortion of spatial and body perception (feeling flattened, stretched, or pulled through surfaces); loss of awareness of one's physical body; immersive visionary states; encounter with entity-like presences or "guides"; perception of being in a fundamentally different reality or dimension; uncontrollable laughter; dysphoria or anxiety
• The experience is frequently described as qualitatively unlike other psychedelics — characterized by a "mechanical" or "uncanny" quality, spatial disorientation, and dissolution of the boundary between self and environment

2. CREDIBLE CLAIMS (Tier 2 — Academic / Debated but Supported)

2.1 Neuroscience of KOR Agonism

• The subjective effects of salvinorin A provide a unique window into the role of the kappa-opioid receptor in consciousness — KOR activation modulates dopamine release (suppressing mesolimbic dopamine — producing dysphoria), alters glutamatergic signaling, and affects circuits involved in salience, reward, and spatial orientation
• Bryan Roth (2002) first identified salvinorin A as a selective KOR agonist — a landmark discovery that upended the assumption that psychoactive substances must act through monoaminergic systems

2.2 Therapeutic Potential

• Limited preclinical available evidence suggests KOR ligands (including salvinorin A analogs) may have therapeutic potential for depression, addiction, and pain — but salvinorin A itself has a very short duration of action and dysphoric effects, limiting its direct clinical utility; semi-synthetic analogs with modified pharmacokinetics are under investigation

3. SPECULATIVE CLAIMS (Tier 3 — Possible but Unverified)

3.1 Salvia Divinorum as Ancient Aztec Pipiltzintzintli

• Researchers (Valdés, Díaz) have proposed that Salvia divinorum may be the mysterious pipiltzintzintli mentioned in colonial-era Aztec sources — a psychoactive plant used by Aztec priests; the identification remains debated, as other candidates have also been proposed (including Salvia spp., Cannabis, and morning glory)

4. DUBIOUS CLAIMS (Tier 4 — No Credible Source / Contradicted by Evidence)

4.1 No Legitimate Research Interest

• [REFUTED] Media characterizations of Salvia divinorum as merely a "legal high" with no scientific significance — the discovery of salvinorin A as a non-alkaloid KOR agonist was a major pharmacological finding, and the compound remains an active tool in neuroscience research into kappa-opioid function, consciousness, and potential therapeutic applications

COUNTER-ARGUMENTS AND CRITICAL PERSPECTIVES

Safety Concerns from Uncontrolled Use

Smoked salvinorin A produces rapid, intense dissociation that eliminates awareness of physical surroundings — case reports document falls, injuries, and dangerous behavior (walking into traffic, attempted self-harm) during intoxication. Unlike classical psychedelics where a "sitter" can verbally guide a distressed individual, salvia users often become completely unreachable during peak effects. The intensity and unpredictability of smoked concentrated extracts (5x–100x) far exceeds the traditional Mazatec chewed-leaf preparation, raising genuine safety concerns about recreational use.

Limited Therapeutic Viability of Salvinorin A Itself

Despite interest in KOR pharmacology for depression and addiction, salvinorin A’s extremely short duration of action (5–15 minutes smoked), intense dysphoria, and dissociative effects make it poorly suited as a direct therapeutic agent. Semi-synthetic analogs with longer duration and reduced dissociative effects are under development, but none have entered clinical trials as of 2025. The gap between preclinical KOR research and translatable therapies remains large.

Scheduling Debate: Protection vs. Research Restriction

Scheduling Salvia divinorum as a controlled substance (as some US states and countries have done) creates a tension: restrictions protect against unregulated recreational use but simultaneously impede pharmacological research on a unique KOR probe molecule. The DEA considered federal scheduling but has not acted, and the scientific community remains divided on whether prohibition or regulated access better serves public health and research goals.

Ethnobotanical Knowledge Context

Western pharmacological extraction of salvinorin A from Salvia divinorum decontextualizes the compound from the Mazatec ceremonial framework (set, setting, intention, curandero guidance) that traditionally governed its use. Critics note that reducing a complex ethnobotanical practice to a single active compound risks both mischaracterizing the traditional experience and disregarding Indigenous intellectual property.

IMAGES

No images assigned yet.

BIBLIOGRAPHY

1. Valdés, Leander J., III, et al. . )90004-1 | 1983 | "Ethnopharmacology of Ska María Pastora (Salvia divinorum, Epling and Játiva-M.)" | Journal of Ethnopharmacology | ∅ | 7.3::287–312 | ∅ | ∅ | doi:10.1016/0378-8741(83 | ∅ | ∅ | ∅
2. Roth, Bryan L., et al | 2002 | "Salvinorin A: A Potent Naturally Occurring Nonnitrogenous κ Opioid Selective Agonist" | Proceedings of the National Academy of Sciences | ∅ | 99.18::11934–11939 | ∅ | ∅ | doi:10.1073/pnas.182234399 | ∅ | ∅ | ∅
3. Addy, Peter H | 2012 | "Acute and Post-Acute Behavioral and Psychological Effects of Salvinorin A in Humans" | Psychopharmacology | ∅ | 220.1::195–204 | ∅ | ∅ | doi:10.1007/s00213-011-2470-6 | ∅ | ∅ | ∅
4. Siebert, Daniel J. . )90116-3 | 1994 | "Salvia Divinorum and Salvinorin A: New Pharmacologic Findings" | Journal of Ethnopharmacology | ∅ | 43.1::53–56 | ∅ | ∅ | doi:10.1016/0378-8741(94 | ∅ | ∅ | ∅
5. Prisinzano, Thomas E | 2005 | "Psychopharmacology of the Hallucinogenic Sage Salvia Divinorum" | Life Sciences | ∅ | 78.5::527–531 | ∅ | ∅ | doi:10.1016/j.lfs.2005.09.008 | ∅ | ∅ | ∅
6. Maqueda, Amanda E., et al. pyv065 | 2015 | "Salvinorin-A Induces Intense Dissociative Effects, Blocking External Sensory Perception and Modulating Interoception and Sense of Body Ownership in Humans" | International Journal of Neuropsychopharmacology | ∅ | 18.12:: | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
7. Wasson, R | 1962 | "A New Mexican Psychotropic Drug from the Mint Family" | Botanical Museum Leaflets, Harvard University | ∅ | 20.3::77–84 | Gordon | ∅ | ∅ | ∅ | ∅ | ∅
8. Cunningham, C | 2011 | "Neuropharmacology of the Naturally Occurring κ-Opioid Hallucinogen Salvinorin A" | Pharmacological Reviews | ∅ | 63.2::316–347 | W., et al | ∅ | ∅ | ∅ | ∅ | ∅
9. Sheffler, Douglas J.; Bryan L | 2003 | "Salvinorin A: The 'Magic Mint' Hallucinogen Finds a Molecular Target in the Kappa Opioid Receptor" | Trends in Pharmacological Sciences | ∅ | 24.3::107–109 | Roth | ∅ | ∅ | ∅ | ∅ | ∅
10. Vortéréan, Jean-Paul, et al | 2013 | "Salvia Divinorum: Clinical and Research Potential" | Psychopharmacology | ∅ | 230.3::151–160 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
11. Butelman, Eduardo R., et al | 2012 | "Kappa-Opioid Receptor/Dynorphin System: Genetic and Pharmacotherapeutic Implications for Addiction" | Trends in Neurosciences | ∅ | 35.10::587–596 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
12. Chavkin, Charles | 2011 | "The Therapeutic Potential of κ-Opioids for Treatment of Pain and Addiction" | Neuropsychopharmacology | ∅ | 36.1::369–370 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
13. Díaz, José Luis | 2013 | "Salvia Divinorum: A Psychopharmacological Riddle and a Mind-Body Prospect" | Current Drug Abuse Reviews | ∅ | 6.1::43–53 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
14. Johnson, Matthew W., et al | 2011 | "Human Psychopharmacology and Dose-Effects of Salvinorin A, a Kappa Opioid Agonist Hallucinogen Present in the Plant Salvia Divinorum" | Drug and Alcohol Dependence | ∅ | 2::150–155 | 115.1 | ∅ | ∅ | ∅ | ∅ | ∅
15. Ranganathan, Mohini, et al | 2012 | "Dose-Related Behavioral, Subjective, Endocrine, and Psychophysiological Effects of the κ Opioid Agonist Salvinorin A in Humans" | Biological Psychiatry | ∅ | 72.10::871–879 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
16. MacLean, Katherine A., et al | 2013 | "Dose-Related Effects of Salvinorin A in Humans: Dissociative, Hallucinogenic, and Memory Effects" | Psychopharmacology | ∅ | 226.2::381–392 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
17. Fichna, Jakub, et al | 2009 | "Salvinorin A: From Natural Product to Human Therapeutics" | Archiv der Pharmazie | ∅ | 342.8::443–451 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
18. Schultes, Richard Evans, Albert Hofmann; Christian Rätsch | 2001 | ∅ | Plants of the Gods: Their Sacred, Healing, and Hallucinogenic Powers | ∅ | ∅ | Rochester, VT: Healing Arts Press | ∅ | isbn:9780892819799 | ∅ | ∅ | ∅
19. Valdés, Leander J., III | 1994 | "Salvia Divinorum and the Unique Diterpene Hallucinogen, Salvinorin (Divinorin) A" | Journal of Psychoactive Drugs | ∅ | 26.3::277–283 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
20. Tejeda, Hugo A., et al | 2013 | "Prefrontal Cortical Kappa-Opioid Receptor Modulation of Local Neurotransmission and Conditioned Place Aversion" | Neuropsychopharmacology | ∅ | 38.9::1770–1779 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅
21. Babu, Kavita M., et al | 2008 | "Opioid Receptors and Legal Highs: Salvia Divinorum and Kratom" | Clinical Toxicology | ∅ | 46.2::146–152 | ∅ | ∅ | ∅ | ∅ | ∅ | ∅

CROSS-REFERENCE INDEX

Generated from V4 expansion plan. Last Updated: March 11, 2026

<table border="1" cellpadding="12" cellspacing="0" style="border-collapse: collapse; border: 2px solid #888; margin-top: 2em; background: #fafafa;">

<tr><td>

⚠️ AI-Assisted Research Disclaimer

This document was generated and structured with the assistance of AI tools.

While every effort is made to ensure accuracy, AI-assisted content may

contain errors, misattributions, or unintended inaccuracies. **Always

verify claims, dates, and sources independently** before citing or relying

on any information presented here.

• Sources may contain errors. Bibliography entries and cross-references

are checked by automated systems, but mistakes can occur. If something

looks wrong, it may be.

• Speculative and unverified claims are clearly labeled. This project

uses a four-tier evidence system:

• Tier 1 — Verified: Peer-reviewed, established scientific consensus.
• Tier 2 — Credible: Academically supported, debated but grounded.
• Tier 3 — Speculative: Plausible but unverified by mainstream science.
• Tier 4 — Dubious: No credible support or contradicted by evidence.
• This project maps multiple perspectives — not a single truth. Mainstream,

alternative, and skeptical viewpoints are presented side by side for

critical comparison, not endorsement. Inclusion does not imply agreement.

• We are actively improving. Source verification, factuality scoring,

and bibliography enrichment are ongoing. Each revision adds stronger

citations, corrects identified errors, and expands coverage.

📖 For full details on our verification methodology, scoring systems, and

quality metrics, see: Fact-Checking & Verification Systems

Think Openly. Check the sources. Draw your own conclusions.

</td></tr>

</table>